Pieris Pharmaceuticals Total Liabilities

Pieris Pharmaceuticals (PIRS) currently reports a total liabilities of $37M as of June 2026. That compares with $26M in the prior-year period — up 40.9% year over year. Use the charts on this page to explore Pieris Pharmaceuticals's total liabilities history and peer comparisons.

Pieris Pharmaceuticals's total liabilities increased from $26M to $37M — a 40.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pieris Pharmaceuticals reported $37M in total liabilities as of June 2026. That compares with $26M in the prior-year period — up 40.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $37M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pieris Pharmaceuticals, and consider following PIRS for alerts when major investors trade the stock.

Pieris Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $37M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PIRS with unrelated industries.